5 of 23 articles - Show All
  1. Udenafil: efficacy and tolerability in the management of erectile dysfunction.

    Therapeutic advances in urology , Volume 5 , Issue 2 (2013)
    Kang S G , Kim J J
  2. Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study.

    International journal of impotence research , Volume 26 , Issue 2 (2014)
    Shim Y S , Pae C , Cho K J , Kim S W , Kim J C , Koh J S
  3. Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study.

    International journal of impotence research , Volume 23 , Issue 3 (2011)
    Shim Y S , Pae C , Kim S W , Kim H W , Kim J C , Koh J S
  4. Phosphodiesterase inhibitors as potential cognition enhancing agents.

    Current topics in medicinal chemistry , Volume 10 , Issue 2 (2010)
    Schmidt C J
  5. Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

    British journal of pharmacology , Volume 164 , Issue 8 (2011)
    Cuadrado-Tejedor M , Hervias I , Ricobaraza A , Puerta E , Pérez-Roldán J M , García-Barroso C , Franco R , Aguirre N , García-Osta A
(No collections found)